• Major sources of vital statistics such as Sample
Registration System, Civil Registration Systems, and National Family Health Survey. In addition, disease registries on specific diseases are available such as the Indian Council of Medical Research or ICMR cancer registry program, national stroke registry and they need to be brought under surveillance. [17, 18] While surveillance through the use of population-based registries is critical for monitoring disease trends and evaluating NCD control programs, these need to be evaluated to assess quality parameters such as data validity, timeliness, and representativeness [19] • Other data available from research studies, existing monitoring, and evaluation systems can be used along with other sources of data to estimate the burden of disease.
3. [20] urges each country to integrate NCD surveillance with existing surveillance and monitoring systems, as well as into existing national health information systems. It is thus expected that surveillance be recognised as a critical component of NCD program and adequate funding be set aside for this purpose, that all available data from various sources will be collected and analyzed to estimate the burden of disease, and that surveillance data be made available widely including on the program website and used for program planning and monitoring and evaluation. Finally, good surveillance data can play a critical role in good decision-making and ultimately for better delivery of NCD services. Experience shows that intuitively the programs which have had a better surveillance program or more reliable data, have had more success or had better program performance. It is also imperative to periodically evaluate surveillance system and assess it is quality and usefulness. The evaluation data so obtained can then be used to further improve the system.
Introduction
Nepal is a developing country where rural communities constitute 80% of the total population. [1] With changing lifestyles, urban influence, and improving health-care access, diabetes mellitus is increasingly diagnosed in rural population. [2, 3] Diabetes ranks fourth among the noncommunicable diseases (NCDs) regarding proportional mortality in Nepal. [4] A meta-analysis suggested that the prevalence of diabetes in urban and rural communities is 8.1% and 1%, respectively. [5, 6] Alarmed by the prevalence and impact of diabetes in resource-limited health-care settings. [7] Bayalpata Hospital is a primary care district hospital which serves almost 300 patients per day in the outpatient department and has a catchment population of 150,000. The hospital has primary care physicians and health assistants work together to screen diabetes along with other NCDs in susceptible individuals and facilitate management. The health assistants examine, investigate, and prescribe medications and seek consultations with physicians on need basis. Health assistants are effective and cost-effective in mitigating the problem of health personnel shortage in rural community and in providing quality health care. [8, 9] The hospital utilizes electronic medical record system to strengthen protocol-based care and possesses a robust team of community health workers to ensure regular patients' follow-ups in the hospital. The hospital has a formulary of around 300 drugs including metformin, glimepiride, and premixed 30:70 insulin as recommended by the PEN protocol and national list of essential medicines. [10, 11] The study aimed to measure the burden of diabetes in the rural hospital setting, to evaluate the team efficiency in the care of diabetes patients, and to determine the sufficiency of therapeutic armamentarium.
Subjects and Methods
The study was carried out in the patients attending the Outpatient Department of Bayalpata hospital, located in one of the most rural settings in Nepal. It takes nearly 10 h to reach nearest multispecialty hospitals. This was a descriptive study and was undertaken as a part of quality improvement project for diabetes care. Data were collected from the electronic medical record system of the hospital for the duration of 5 months from November 1, 2017 to March 31, 2018. All the patients visiting the outpatient department and having the diagnosis of diabetes were enrolled in the study. Prior approval was obtained from the hospital administration for data extraction from its electronic medical record system.
We collected data of patients including gender; age; investigations such as fasting and postprandial plasma glucose levels, glycated hemoglobin (HbA1c), and urine protein; comorbidities; and medicines prescribed. In the institutional protocol, diabetes was diagnosed as per the American Diabetes Association (ADA) guidelines 2017 when (i) the patient was clinically symptomatic with random plasma glucose ≥200 mg/dl or (ii) the fasting plasma glucose was ≥126 mg/dl and 2-h postprandial plasma glucose was ≥200 mg/dl. [2] The classic symptoms of diabetes were polyuria, polydipsia, and unexplained weight loss. The new cases were described as cases diagnosed during the study period and the follow-up cases were the ones that were diagnosed before the study period. The outcomes after pharmacotherapy with available medications such as metformin, glimepiride, and insulin 30:70 were also evaluated in terms of control of plasma glucose on follow-up. The control of plasma glucose was assessed after at least two visits. The "control" of plasma glucose was termed when the fasting plasma glucose was 90-130 mg/dl and 2-h postprandial plasma glucose was <180 mg/dl. When only the fasting plasma glucose was under control, it was termed as "partial control" and if neither of the fasting nor postprandial plasma glucose was within expected range, the plasma glucose was termed as "not under control." Those cases that failed to follow-up during the last 2 months of the study were labeled as "failed to follow-up." The patients had to visit the hospital every month for refills of medications. 
Results
The total diabetic patient visits during the study period were 682 of 30,758 total outpatient visits (2%). However, there were 240 unique diabetic patients including new and follow-up cases. The new and follow-up patients were 59 (24.6%) and 181 (75.4%), respectively. Diabetes was observed more in males (187, 77.9%) than females (53, 22.1%) (P = 0.000). The age of the diabetes patients ranged from 25 to 82 years with the median age of 52 and interquartile range of 47-63. Diabetes was the most common in the age group of 41-50 years (P = 0.000) [ Figure 1 ].
HbA1c was done in 15 of 59 new cases and ranged from 5.5% to 14%. The mean HbA1c at presentation was 8.9% ± 2.7%. Similarly, HbA1c was performed in 33 of
